Cargando…
Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity
The quadrivalent HPV vaccine (4vHPV) was originally recommended as a three-dose series (0/2/6 months), though delays in completing the series frequently occur. We previously found delayed dosing in girls resulted in similar or higher antibody titers compared to on-time dosing. Archived sera from 262...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482794/ https://www.ncbi.nlm.nih.gov/pubmed/31967933 http://dx.doi.org/10.1080/21645515.2019.1706410 |